The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer

por El Ansari, Rokaya, Alfarsi, Lutfi, Craze, Madeleine L., Masisi, Brendah K., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2020

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

por El Ansari, Rokaya, Craze, Madeleine L., Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2018

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

por Alfarsi, Lutfi H., El Ansari, Rokaya, Craze, Madeleine L., Masisi, Brendah K., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2020

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

por El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2018

Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer

por Alfarsi, Lutfi H., El Ansari, Rokaya, Masisi, Brendah K., Parks, Ruth, Mohammed, Omar J, Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2020

Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer

por Alfarsi, Lutfi H., El-Ansari, Rokaya, Craze, Madeleine L., Masisi, Brendah K., Mohammed, Omar J., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2020

SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer

por Alfarsi, Lutfi H., El Ansari, Rokaya, Craze, Madeleine L., Mohammed, Omar J., Masisi, Brendah K., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Publicado 2021

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer

por Masisi, Brendah K., El Ansari, Rokaya, Alfarsi, Lutfi, Craze, Madeleine L., Jewa, Natasha, Oldfield, Andrew, Cheung, Hayley, Toss, Michael, Rakha, Emad A., Green, Andrew R.
Publicado 2021

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative...

por Morotti, Matteo, Zois, Christos E., El-Ansari, Rokaya, Craze, Madeleine L., Rakha, Emad A., Fan, Shih-Jung, Valli, Alessandro, Haider, Syed, Goberdhan, Deborah C. I., Green, Andrew R., Harris, Adrian L.
Publicado 2020

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer

por Craze, Madeleine L, Cheung, Hayley, Jewa, Natasha, Coimbra, Nuno D M, Soria, Daniele, El-Ansari, Rokaya, Aleskandarany, Mohammed A, Wai Cheng, Kiu, Diez-Rodriguez, Maria, Nolan, Christopher C, Ellis, Ian O, Rakha, Emad A, Green, Andrew R
Publicado 2018